enVVeno Medical Corporation (NVNO)
USD 2.48
(-4.25%)
USD 2.48
(-4.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -25.01 Million USD | -2.08% |
| 2022 | -24.5 Million USD | -46.3% |
| 2021 | -16.75 Million USD | -86.91% |
| 2020 | -8.75 Million USD | -34.99% |
| 2019 | -6.96 Million USD | 10.29% |
| 2018 | -6.04 Million USD | 3.55% |
| 2017 | -5.73 Million USD | -70.23% |
| 2016 | -5.37 Million USD | -287.14% |
| 2015 | -1.16 Million USD | -42.26% |
| 2014 | -818.53 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -5.31 Million USD | 0.82% |
| 2024 Q1 | -5.36 Million USD | 12.73% |
| 2024 Q3 | -6.17 Million USD | -13.6% |
| 2023 Q2 | -6.97 Million USD | 0.63% |
| 2023 FY | - USD | -0.75% |
| 2023 Q1 | -7.02 Million USD | -6.93% |
| 2023 Q3 | -5.51 Million USD | 20.95% |
| 2023 Q4 | -6.14 Million USD | -11.41% |
| 2022 Q1 | -5.2 Million USD | 41.31% |
| 2022 FY | - USD | -46.3% |
| 2022 Q4 | -6.56 Million USD | -9.49% |
| 2022 Q3 | -5.99 Million USD | 11.02% |
| 2022 Q2 | -6.74 Million USD | -29.47% |
| 2021 FY | - USD | -86.91% |
| 2021 Q3 | -2.89 Million USD | -27.27% |
| 2021 Q2 | -2.27 Million USD | 15.77% |
| 2021 Q1 | -2.7 Million USD | 33.42% |
| 2021 Q4 | -8.87 Million USD | -205.98% |
| 2020 Q2 | -1.36 Million USD | 4.3% |
| 2020 Q4 | -4.06 Million USD | -129.42% |
| 2020 FY | - USD | -34.99% |
| 2020 Q1 | -1.42 Million USD | 10.93% |
| 2020 Q3 | -1.77 Million USD | -30.08% |
| 2019 Q4 | -1.59 Million USD | 6.66% |
| 2019 FY | - USD | 10.29% |
| 2019 Q3 | -1.71 Million USD | 7.5% |
| 2019 Q2 | -1.84 Million USD | -24.78% |
| 2019 Q1 | -1.48 Million USD | -2.54% |
| 2018 Q3 | -1.45 Million USD | 71.4% |
| 2018 Q4 | -1.44 Million USD | 0.59% |
| 2018 FY | - USD | 3.55% |
| 2018 Q1 | -5.99 Million USD | -66.21% |
| 2018 Q2 | -5.08 Million USD | 15.17% |
| 2017 Q3 | -1.77 Million USD | -45.93% |
| 2017 FY | - USD | -70.23% |
| 2017 Q1 | -1.09 Million USD | 0.09% |
| 2017 Q2 | -1.21 Million USD | -11.46% |
| 2017 Q4 | -3.6 Million USD | -102.66% |
| 2016 Q2 | -1.19 Million USD | -0.0% |
| 2016 Q3 | -1.01 Million USD | 14.81% |
| 2016 Q1 | -1.19 Million USD | -115.89% |
| 2016 Q4 | -1.09 Million USD | -7.38% |
| 2016 FY | - USD | -287.14% |
| 2015 Q4 | -554.36 Thousand USD | 0.0% |
| 2015 FY | - USD | -42.26% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -85.497% |
| Cerus Corporation | -26.53 Million USD | 5.721% |
| OrthoPediatrics Corp. | -8.38 Million USD | -198.509% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -138.392% |
| Talis Biomedical Corporation | -66.04 Million USD | 62.12% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -50.033% |
| Inogen, Inc. | -45.67 Million USD | 45.231% |
| Spectral AI, Inc. | -12.26 Million USD | -104.029% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 47.544% |
| CVRx, Inc. | -38.73 Million USD | 35.406% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -609.127% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -106.641% |
| Orthofix Medical Inc. | -86.98 Million USD | 71.239% |
| Venus Concept Inc. | -26.11 Million USD | 4.193% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 49.734% |
| Bioventus Inc. | -23.07 Million USD | -8.444% |
| BrainsWay Ltd. | -2.31 Million USD | -982.562% |
| Envoy Medical, Inc. | -18.23 Million USD | -37.175% |
| electroCore, Inc. | -17.76 Million USD | -40.867% |
| IceCure Medical Ltd | -15.25 Million USD | -64.02% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 49.714% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -48.425% |
| MaxCyte, Inc. | -44.12 Million USD | 43.306% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -112.811% |
| Nexalin Technology, Inc. | -5.69 Million USD | -339.526% |
| PAVmed Inc | -75.74 Million USD | 66.969% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 53.462% |
| RxSight, Inc. | -41.03 Million USD | 39.036% |
| Sight Sciences, Inc. | -49.41 Million USD | 49.372% |
| SI-BONE, Inc. | -34.44 Million USD | 27.37% |
| TELA Bio, Inc. | -40.63 Million USD | 38.429% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 57.086% |
| Treace Medical Concepts, Inc. | -39 Million USD | 35.864% |
| LivaNova PLC | 39.01 Million USD | 164.122% |
| 908 Devices Inc. | -34.02 Million USD | 26.472% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 77.378% |
| Nemaura Medical Inc. | -7.28 Million USD | -243.321% |
| NeuroPace, Inc. | -22.83 Million USD | -9.565% |
| LENSAR, Inc. | -8.71 Million USD | -187.101% |
| Apyx Medical Corporation | -18.11 Million USD | -38.129% |
| Cutera, Inc. | -136.56 Million USD | 81.68% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -640.178% |
| BioSig Technologies, Inc. | -28.15 Million USD | 11.129% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1094.356% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -19.196% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 106.522% |
| Axonics, Inc. | 7.77 Million USD | 421.775% |
| Outset Medical, Inc. | -153.78 Million USD | 83.732% |
| IRIDEX Corporation | -7.44 Million USD | -235.902% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 74.496% |
| IRadimed Corporation | 20.8 Million USD | 220.275% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -210.32% |
| INVO Bioscience, Inc. | -6.88 Million USD | -263.633% |
| Telesis Bio, Inc. | -40.49 Million USD | 38.216% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 168.212% |
| Varex Imaging Corporation | 67.2 Million USD | 137.229% |
| Quipt Home Medical Corp. | 44.07 Million USD | 156.767% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -130.156% |
| Pulmonx Corporation | -55.09 Million USD | 54.589% |
| Dynatronics Corporation | -976 Thousand USD | -2463.299% |
| Modular Medical, Inc. | -17.1 Million USD | -46.278% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -72.717% |
| Semler Scientific, Inc. | 23.58 Million USD | 206.058% |
| InMode Ltd. | 196.28 Million USD | 112.746% |
| Bruker Corporation | 599 Million USD | 104.177% |
| Cytosorbents Corporation | -28.81 Million USD | 13.165% |
| DexCom, Inc. | 916.7 Million USD | 102.729% |
| Align Technology, Inc. | 799.03 Million USD | 103.131% |
| Viveve Medical, Inc. | -20.61 Million USD | -21.346% |
| ZimVie Inc. | 91.07 Million USD | 127.47% |
| Movano Inc. | -29.12 Million USD | 14.101% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -467.559% |
| Nexalin Technology, Inc. | -5.69 Million USD | -339.526% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -609.127% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 87.148% |
| Profound Medical Corp. | -27.12 Million USD | 7.762% |
| Insulet Corporation | 323.6 Million USD | 107.731% |
| Surmodics, Inc. | 1.18 Million USD | 2205.892% |
| iCAD, Inc. | -6.56 Million USD | -281.081% |
| Nuwellis, Inc. | -16.35 Million USD | -52.959% |
| Biotricity, Inc. | -8.82 Million USD | -183.385% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 74.172% |
| Aethlon Medical, Inc. | -11.84 Million USD | -111.138% |
| InspireMD, Inc. | -20.91 Million USD | -19.64% |
| PAVmed Inc. | -75.74 Million USD | 66.969% |
| BIOLASE, Inc. | -15.13 Million USD | -65.255% |
| Beyond Air, Inc. | -59.03 Million USD | 57.619% |
| FONAR Corporation | 28.25 Million USD | 188.554% |
| AxoGen, Inc. | -13.32 Million USD | -87.71% |
| Vivani Medical, Inc. | -26.6 Million USD | 5.976% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 201.944% |
| Inari Medical, Inc. | 7.11 Million USD | 451.722% |
| UFP Technologies, Inc. | 72.74 Million USD | 134.392% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -638.913% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -306.401% |
| Tenon Medical, Inc. | -15.52 Million USD | -61.115% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -63.881% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 39.68% |
| AdaptHealth Corp. | -171.09 Million USD | 85.377% |
| Sintx Technologies, Inc. | -6.6 Million USD | -279.061% |
| NanoVibronix, Inc. | -3.43 Million USD | -628.326% |
| Quanterix Corporation | -38.08 Million USD | 34.315% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -130.156% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 83493.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 90.977% |
| TransMedics Group, Inc. | -7.6 Million USD | -229.054% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -14.946% |
| NeuroMetrix, Inc. | -7.09 Million USD | -252.574% |
| Hyperfine, Inc. | -47.06 Million USD | 46.839% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 57.093% |
| Biomerica, Inc. | -5.99 Million USD | -317.454% |
| Bone Biologics Corporation | 479.57 Thousand USD | 5316.735% |
| AVITA Medical, Inc. | -39.56 Million USD | 36.772% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -172.737% |
| Silk Road Medical, Inc | -45.08 Million USD | 44.503% |